Rayzebio Inc (RYZB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | 06-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -48,802 | -30,611 | N/A | -53,898 | -33,451 |
| Depreciation Amortization | -4,570 | -2,801 | N/A | 1,631 | 1,224 |
| Accounts payable and accrued liabilities | 1,765 | 488 | N/A | 929 | 1,399 |
| Other Working Capital | 718 | 651 | N/A | 319 | 615 |
| Other Operating Activity | 5,629 | 4,276 | 0 | 10,127 | 1,554 |
| Operating Cash Flow | $-45,260 | $-27,997 | $N/A | $-40,892 | $-28,659 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -31,811 | -18,287 | N/A | -6,296 | -3,695 |
| Purchase Of Investment | -292,489 | -175,475 | N/A | -50,082 | -17,231 |
| Sale Of Investment | 177,530 | 122,530 | N/A | 104,448 | 62,492 |
| Investing Cash Flow | $-146,770 | $-71,232 | $N/A | $48,070 | $41,566 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 314,835 | 3,283 | N/A | 87 | 77 |
| Common Stock Repurchased | N/A | N/A | N/A | -1,876 | -1,864 |
| Other Financing Activity | 0 | 0 | 0 | 159,684 | 0 |
| Financing Cash Flow | $314,835 | $3,283 | $N/A | $157,895 | $-1,787 |
| Beginning Cash Position | 129,498 | 129,498 | N/A | 50,851 | 50,851 |
| End Cash Position | 252,303 | 33,552 | N/A | 215,924 | 61,971 |
| Net Cash Flow | $122,805 | $-95,946 | $N/A | $165,073 | $11,120 |
| Free Cash Flow | |||||
| Operating Cash Flow | -45,260 | -27,997 | N/A | -40,892 | -28,659 |
| Capital Expenditure | -31,811 | -18,287 | N/A | -6,296 | -3,695 |
| Free Cash Flow | -77,071 | -46,284 | 0 | -47,188 | -32,354 |